Should Celestica Stock Be in Your Portfolio Pre-Q1 Earnings?

Celestica, Inc. CLS is scheduled to report first-quarter 2025 earnings on April 24. The Zacks Consensus Estimate for sales and earnings is pegged at $2.55 billion and $1.10 per share, respectively. Earnings estimates for CLS have moved up from $4.75 per share to $4.78 for 2025 and from $5.67 per share to $5.93 for 2026, over the past 60 days.CLS Estimate TrendImage Source: Zacks Investment ResearchEarnings Surprise HistoryThe leading electronics manufacturing services firm has had a solid earnings surprise history in the trailing four quarters, exceeding earnings expectations on most occasions. It delivered a four-quarter earnings surprise of 10.3%, on average, matching estimates in the last reported quarter. (See the Zacks Earnings Calendar to stay ahead of market-making news.)Image Source: Zacks Investment ResearchEarnings WhispersOur proven model does not predict an earnings beat for Celestica for the first quarter. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold) increases the chances of an earnings beat. That is not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter. Celestica currently has an ESP of 0.00% with a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.Factors Shaping Upcoming ResultsCelestica is witnessing healthy traction in the Connectivity & Cloud Solutions segment. Strong demand for AI/ML compute products is expected to have driven revenues in the enterprise-end market in the quarter. Healthy demand for networking products, including 400G switches and 800G switches, is likely to have propelled net sales growth in the communications end market.However, the Advanced Technology Solutions segment is expected to have been plagued by weakness in the Industrial end market. Strength in commercial aviation and several defense customer wins in the aerospace & defense end market might have partially cushioned net sales in this segment. Signs of recovery in the wafer fabrication equipment market are a tailwind for the capital equipment vertical.Price PerformanceOver the past year, CLS has surged 95.6% compared with the industry’s growth of 31.5%. It has also outperformed its peers like Flex Ltd. FLEX and Jabil Inc. JBL over this period. Flex has gained 14.2% and Jabil is up 13.4% over this period. With a presence across 100 locations in 30 countries, Jabil is riding on secular growth drivers with strong margin and cash flow dynamics. On the other hand, Flex is thriving on low-cost manufacturing.Image Source: Zacks Investment ResearchKey Valuation MetricFrom a valuation standpoint, Celestica appears to be trading at a premium relative to the industry and is trading well above its mean. Going by the price/earnings ratio, the company shares currently trade at 16.38 forward earnings, higher than 14.72 for the industry and the stock’s mean of 8.4. Image Source: Zacks Investment ResearchInvestment ConsiderationsCelestica's extensive portfolio supports various customer requirements from low-volume, high-complexity custom products to high-volume commodity products. The company’s strong emphasis on innovation, product diversification and AI advancements drives growth. The rapid adoption of AI, data centers by enterprises across industries presents solid growth potential for Celestica. Focus on production efficiency and effective working capital management boost profitability and free cash flow. Healthy momentum in several end markets, including enterprise, communication, aerospace and defense, augurs well for the company ahead of first-quarter results. However, Celestica is experiencing demand softness in the Industrial end market owing to macroeconomic challenges and excess channel inventory. The company relies on raw material supplies from certain areas of Eastern Europe and the Middle East. The ongoing conflicts in those regions remain a major concern for its supply chain. In addition, growing geopolitical tension between China and Taiwan can adversely impact its business in Asia.End NoteCelestica seems to be treading in the middle of the road, and investors could be better off if they trade with caution. Moreover, CLS is trading at premium valuation metrics, and new investors could wait for a better entry point to cash in on its long-term fundamentals. However, a single quarter’s results are not so important for long-term stakeholders and investors already owning the stock could stay put. With improving earnings estimates, the stock is witnessing a positive investor perception. Riding on a diverse portfolio of products that form an integral part of AI applications, Celestica’s remarkable transformation in recent years offers a competitive edge across the broader technology market. The company is well poised for sustained growth over the years, backed by its robust infrastructure investments, solid technology know-how and wide industry experience.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Jabil, Inc. (JBL): Free Stock Analysis Report Flex Ltd. (FLEX): Free Stock Analysis Report Celestica, Inc. (CLS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks